Transthyretin Amyloidosis Treatment Market Trends and Analysis 2034

Ajouter une nouvelle offre d'emploi Health

2025-08-18 12:36:44 -

Transthyretin amyloidosis (ATTR) is a progressive, potentially fatal disorder characterized by the accumulation of misfolded transthyretin proteins in tissues, causing damage mainly to the heart and nerves. Treatment aims to slow or halt the production of these abnormal proteins, manage symptoms, and enhance patients' quality of life. Current options include targeted therapies like tafamidis...

0 Commentaires 0 Parts 455 Vue 0 Aperçu